Exploring risk factors for re-hospitalization in a psychiatric inpatient setting: a retrospective naturalistic study.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
22 12 2022
Historique:
received: 06 06 2022
accepted: 14 12 2022
entrez: 22 12 2022
pubmed: 23 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

The reduction of multiple psychiatric hospitalizations is an important clinical challenge in mental health care. In fact, psychiatric re-hospitalization negatively affects the quality of life and the life expectancy of patients with psychiatric disorders. For these reasons, identifying predictors of re-hospitalization is important for better managing psychiatric patients. The first purpose of the present study was to examine the readmission rate in a large sample of inpatients with a psychiatric disorder. Second, we investigated the role of several demographical and clinical features impacting re-hospitalization.  METHOD: This retrospective study enrolled 1001 adult inpatients (510 men and 491 women) consecutively admitted to the University Psychiatric Clinic, Sant'Andrea Hospital, Sapienza University of Rome between January 2018 and January 2022. To identify risk factors for psychiatric re-hospitalization, we divided the sample into 3 subgroups: the Zero-Re group which had no readmission after the index hospitalization, the One-Re group with patients re-admitted only once, and the Two-Re with at least two re-admissions.  RESULTS: The groups differed according to previous hospitalizations, a history of suicide attempts, age at onset, and length of stay. Furthermore, the results of the regression model demonstrated that the Two-Re group was more likely to have a history of suicide attempts and previous hospitalizations. These results indicate the importance of assessing risk factors in psychiatric hospitalized patients and implementing ad hoc prevention strategies for reducing subsequent re-hospitalizations.

Sections du résumé

BACKGROUND
The reduction of multiple psychiatric hospitalizations is an important clinical challenge in mental health care. In fact, psychiatric re-hospitalization negatively affects the quality of life and the life expectancy of patients with psychiatric disorders. For these reasons, identifying predictors of re-hospitalization is important for better managing psychiatric patients. The first purpose of the present study was to examine the readmission rate in a large sample of inpatients with a psychiatric disorder. Second, we investigated the role of several demographical and clinical features impacting re-hospitalization.  METHOD: This retrospective study enrolled 1001 adult inpatients (510 men and 491 women) consecutively admitted to the University Psychiatric Clinic, Sant'Andrea Hospital, Sapienza University of Rome between January 2018 and January 2022. To identify risk factors for psychiatric re-hospitalization, we divided the sample into 3 subgroups: the Zero-Re group which had no readmission after the index hospitalization, the One-Re group with patients re-admitted only once, and the Two-Re with at least two re-admissions.  RESULTS: The groups differed according to previous hospitalizations, a history of suicide attempts, age at onset, and length of stay. Furthermore, the results of the regression model demonstrated that the Two-Re group was more likely to have a history of suicide attempts and previous hospitalizations.
DISCUSSION
These results indicate the importance of assessing risk factors in psychiatric hospitalized patients and implementing ad hoc prevention strategies for reducing subsequent re-hospitalizations.

Identifiants

pubmed: 36550540
doi: 10.1186/s12888-022-04472-3
pii: 10.1186/s12888-022-04472-3
pmc: PMC9783999
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

821

Informations de copyright

© 2022. The Author(s).

Références

Psychiatr Serv. 2008 Sep;59(9):1038-45
pubmed: 18757598
Psychiatr Serv. 2003 Jul;54(7):994-8
pubmed: 12851436
Compr Psychiatry. 2014 Apr;55(3):426-30
pubmed: 24405773
Int J Environ Res Public Health. 2022 Oct 15;19(20):
pubmed: 36293891
Soc Psychiatry Psychiatr Epidemiol. 2008 Jul;43(7):569-74
pubmed: 18347750
J Psychiatr Pract. 2021 Nov 5;27(6):410-416
pubmed: 34768263
Risk Manag Healthc Policy. 2020 May 19;13:433-442
pubmed: 32547274
Aust N Z J Psychiatry. 2011 Jul;45(7):578-85
pubmed: 21718126
J Affect Disord. 2010 Oct;126(1-2):206-13
pubmed: 20334927
Aust Health Rev. 2010 Aug;34(3):282-5
pubmed: 20797358
Front Psychiatry. 2020 Dec 15;11:605140
pubmed: 33384631
Psychiatr Serv. 2013 Dec 1;64(12):1225-9
pubmed: 23945797
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
Eur Psychiatry. 2018 Feb;48:6-12
pubmed: 29331601
Indian J Psychol Med. 2019 Sep 05;41(5):403-412
pubmed: 31548762
Schizophr Res. 2013 May;146(1-3):125-31
pubmed: 23517662
Harv Rev Psychiatry. 2019 Jul/Aug;27(4):209-216
pubmed: 31274577
Soc Psychiatry Psychiatr Epidemiol. 2007 Nov;42(11):916-22
pubmed: 17712501
BMC Psychiatry. 2020 Mar 11;20(1):113
pubmed: 32160906
Psychiatr Serv. 2001 Aug;52(8):1100-2
pubmed: 11474059
Afr J Psychiatry (Johannesbg). 2008 Aug;11(3):187-90
pubmed: 19588041
Suicide Life Threat Behav. 2008 Oct;38(5):539-51
pubmed: 19014306
BMC Psychiatry. 2017 Jun 24;17(1):227
pubmed: 28646857
Braz J Psychiatry. 2012 Jun;34(2):185-92
pubmed: 22729415
Front Psychiatry. 2019 Nov 26;10:828
pubmed: 32038313
Biomedica. 2013 Apr-Jun;33(2):276-82
pubmed: 24652138
Community Ment Health J. 2016 Aug;52(6):675-82
pubmed: 26303903
Psychiatr Serv. 2012 Jul;63(7):666-71
pubmed: 22588167
Pharmacoeconomics. 2021 Jun;39(6):707-720
pubmed: 34043148
Rev Bras Epidemiol. 2017 Jul-Sep;20(3):460-474
pubmed: 29160438
Psychiatry Res. 2020 Oct;292:113309
pubmed: 32702551
Clinics (Sao Paulo). 2010 May;65(5):481-9
pubmed: 20535366
Suicide Life Threat Behav. 2007 Jun;37(3):264-77
pubmed: 17579539
Br J Psychiatry. 1998 Dec;173:531-5
pubmed: 9926085
Isr J Psychiatry Relat Sci. 2011;48(1):49-53
pubmed: 21572243
BMC Psychiatry. 2016 Dec 16;16(1):449
pubmed: 27986079
J Healthc Qual. 2019 Jul/Aug;41(4):228-236
pubmed: 30239473
BMC Psychiatry. 2014 Jun 02;14:161
pubmed: 24888262
Psychiatr Q. 2018 Mar;89(1):33-43
pubmed: 28367585
Psychiatr Serv. 2000 May;51(5):650-5
pubmed: 10783185
Psychiatry Res. 2020 Jan 28;285:112810
pubmed: 32062326
Suicide Life Threat Behav. 2007 Jun;37(3):248-63
pubmed: 17579538
Gen Hosp Psychiatry. 2018 Mar - Apr;51:63-70
pubmed: 29324277
Front Psychiatry. 2018 Mar 07;9:56
pubmed: 29563886
Soc Psychiatry Psychiatr Epidemiol. 2014 Nov;49(11):1719-27
pubmed: 24806950
Psychiatr Serv. 2009 Jun;60(6):786-91
pubmed: 19487348
J Psychiatr Res. 2015 Feb;61:205-13
pubmed: 25537450
J Behav Health Serv Res. 2007 Apr;34(2):137-50
pubmed: 17437186
J Am Acad Child Adolesc Psychiatry. 1996 Sep;35(9):1162-73
pubmed: 8824060
Rev Saude Publica. 2000 Jun;34(3):280-5
pubmed: 10920451

Auteurs

Isabella Berardelli (I)

Department of Neurosciences, Faculty of Medicine and Psychology, Suicide Prevention Centre, Mental Health and Sensory Organs, Sant'Andrea Hospital, Sapienza University of Rome, Via Di Grottarossa, 1035, 00189, Rome, Italy. isabella.berardelli@uniroma1.it.

Salvatore Sarubbi (S)

Department of Human Neurosciences, Sapienza University of Rome, Viale Dell'Università, 30, 00185, Rome, Italy.

Elena Rogante (E)

Department of Human Neurosciences, Sapienza University of Rome, Viale Dell'Università, 30, 00185, Rome, Italy.

Denise Erbuto (D)

Department of Neurosciences, Faculty of Medicine and Psychology, Suicide Prevention Centre, Mental Health and Sensory Organs, Sant'Andrea Hospital, Sapienza University of Rome, Via Di Grottarossa, 1035, 00189, Rome, Italy.

Mariarosaria Cifrodelli (M)

Psychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea Hospital, Psychiatry Unit, Via Di Grottarossa, 1035, 00189, Rome, Italy.

Carlotta Giuliani (C)

Psychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Sant'Andrea Hospital, Psychiatry Unit, Via Di Grottarossa, 1035, 00189, Rome, Italy.

Giuseppa Calabrò (G)

Department of Neurosciences, Faculty of Medicine and Psychology, Suicide Prevention Centre, Mental Health and Sensory Organs, Sant'Andrea Hospital, Sapienza University of Rome, Via Di Grottarossa, 1035, 00189, Rome, Italy.

David Lester (D)

Psychology Program, Stockton University, Galloway, NJ, USA.

Marco Innamorati (M)

Department of Human Sciences, European University of Rome, Via Degli Aldobrandeschi 190, 00163, Rome, Italy.

Maurizio Pompili (M)

Department of Neurosciences, Faculty of Medicine and Psychology, Suicide Prevention Centre, Mental Health and Sensory Organs, Sant'Andrea Hospital, Sapienza University of Rome, Via Di Grottarossa, 1035, 00189, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH